| Dr Ronald L Cook, DO | |
|
3502 9th St, Suite 1c143, Lubbock, TX 79430-8143 | |
| (806) 743-2757 | |
| (806) 743-2563 |
| Full Name | Dr Ronald L Cook |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 3502 9th St, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023000197 | NPI | - | NPPES |
| 100152260A | Medicaid | OK | |
| 110751102 | Medicaid | TX | |
| B002 | Other | NM | TRIWEST |
| J9655 | Medicaid | NM | |
| 71291 | Medicaid | NM | |
| 82G887 | Other | TX | BCBS |
| 71291 | Other | NM | PRESBYTERIAN COMMERCIAL |
| 137761602 | Medicaid | TX | |
| 137761607 | Medicaid | TX | |
| 110751101 | Other | TX | FIRSTCARE COMMERCIAL |
| 80732Z | Other | TX | HMO BLUE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | J6387 (Texas) | Primary |
| 207Q00000X | Family Medicine | J6387 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center | Lubbock, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City Of Lubbock | 4385918770 | 2 |
| Texas Tech University Health Sciences Center Lubbock | 4385549674 | 310 |
News Archive
VION PHARMACEUTICALS, INC., a pharmaceutical company focused on the development of novel cancer therapeutics, announced that it had voluntarily filed for bankruptcy under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
The world's scientific community may be one step closer to understanding age-related memory loss, and to developing a drug that might help boost memory. In an editorial published May 7 in Science, J. David Sweatt, Ph.D., chair of the University of Alabama at Birmingham (UAB) Department of Neurobiology, says that drugs known as histone deacetylase inhibitors are showing great promise in stopping memory loss - and even in boosting the formation of memory in animal models.
The Maine Technology Institute has awarded a $25,000 seed grant to Sandra Rieger, Ph.D., of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and affects an estimated 20 to 40 million Americans.
The Hill: House Minority Leader John Boehner will introduce legislation that would stop Congress from using taxpayer money to support abortions or abortion coverage.
The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers.
› Verified 5 days ago
| Entity Name | Texas Tech University Health Sciences Center Lubbock |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063461358 PECOS PAC ID: 4385549674 Enrollment ID: O20110318000468 |
News Archive
VION PHARMACEUTICALS, INC., a pharmaceutical company focused on the development of novel cancer therapeutics, announced that it had voluntarily filed for bankruptcy under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
The world's scientific community may be one step closer to understanding age-related memory loss, and to developing a drug that might help boost memory. In an editorial published May 7 in Science, J. David Sweatt, Ph.D., chair of the University of Alabama at Birmingham (UAB) Department of Neurobiology, says that drugs known as histone deacetylase inhibitors are showing great promise in stopping memory loss - and even in boosting the formation of memory in animal models.
The Maine Technology Institute has awarded a $25,000 seed grant to Sandra Rieger, Ph.D., of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and affects an estimated 20 to 40 million Americans.
The Hill: House Minority Leader John Boehner will introduce legislation that would stop Congress from using taxpayer money to support abortions or abortion coverage.
The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers.
› Verified 5 days ago
| Entity Name | City Of Lubbock |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528265535 PECOS PAC ID: 4385918770 Enrollment ID: O20171109000826 |
News Archive
VION PHARMACEUTICALS, INC., a pharmaceutical company focused on the development of novel cancer therapeutics, announced that it had voluntarily filed for bankruptcy under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
The world's scientific community may be one step closer to understanding age-related memory loss, and to developing a drug that might help boost memory. In an editorial published May 7 in Science, J. David Sweatt, Ph.D., chair of the University of Alabama at Birmingham (UAB) Department of Neurobiology, says that drugs known as histone deacetylase inhibitors are showing great promise in stopping memory loss - and even in boosting the formation of memory in animal models.
The Maine Technology Institute has awarded a $25,000 seed grant to Sandra Rieger, Ph.D., of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and affects an estimated 20 to 40 million Americans.
The Hill: House Minority Leader John Boehner will introduce legislation that would stop Congress from using taxpayer money to support abortions or abortion coverage.
The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald L Cook, DO Po Box 5865, Lubbock, TX 79408-5865 Ph: (806) 743-2898 | Dr Ronald L Cook, DO 3502 9th St, Suite 1c143, Lubbock, TX 79430-8143 Ph: (806) 743-2757 |
News Archive
VION PHARMACEUTICALS, INC., a pharmaceutical company focused on the development of novel cancer therapeutics, announced that it had voluntarily filed for bankruptcy under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
The world's scientific community may be one step closer to understanding age-related memory loss, and to developing a drug that might help boost memory. In an editorial published May 7 in Science, J. David Sweatt, Ph.D., chair of the University of Alabama at Birmingham (UAB) Department of Neurobiology, says that drugs known as histone deacetylase inhibitors are showing great promise in stopping memory loss - and even in boosting the formation of memory in animal models.
The Maine Technology Institute has awarded a $25,000 seed grant to Sandra Rieger, Ph.D., of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and affects an estimated 20 to 40 million Americans.
The Hill: House Minority Leader John Boehner will introduce legislation that would stop Congress from using taxpayer money to support abortions or abortion coverage.
The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers.
› Verified 5 days ago
Charles Hudson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Concord Medical Group, 1602 Avenue Q, Lubbock, TX 79401 Phone: 972-829-6613 Fax: 800-611-5029 | |
Dr. Scott W. Dahlbeck, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 602 Indiana Ave, Lubbock, TX 79415 Phone: 806-775-8600 Fax: 806-775-8608 | |
Naticia Mortensen, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5915 82nd St, Lubbock, TX 79424 Phone: 806-794-3000 Fax: 806-698-0847 | |
Ryan Daniel Lurtsema, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 4th Street Mail Stop 9901, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-1180 | |
Dr. Cherrylene A Lindgren, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4105 I-27, Lubbock, TX 79404 Phone: 806-762-2633 Fax: 806-761-0431 | |
Jared Zachary Brinker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 |